Scientists Accuse Government of Dishonesty Over GM Babies in its Regulation of new IVF Technique
By Steve Connor,
The Independent
| 07. 28. 2014
Untitled Document
The Government has been accused of misleading the public over the introduction of a new in vitro fertilisation (IVF) technique that some experts believe will result in the birth of “genetically modified babies”.
Leading scientists, including Lord Winston, an early pioneer of fertility treatment, have criticised the Department of Health for trying to play down a process that will for the first time allow the alteration of the DNA of future generations.
They argue that the Government has redefined the term “genetic modification” (GM) to exclude specifically a controversial technique that will result in babies inheriting genetic material from three individuals.
The move, buried within a Department of Health document published last week, is designed to take the sting out of hostility towards mitochondrial donation – a process that aims to avoid the certain inherited diseases being passed on by using healthy mitochondria (microscopic structures in the cell) taken from a donor egg or embryo. Opponents believe that using the healthy donor mitochondria will result in “three-parent embryos” and could usher in an era of “designer babies”...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
